These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9892807)
1. Targets for endothelin in the diseased kidney: clues for therapeutic intervention. Rohmeiss P; Birck R; Braun C; Kirchengast M; van der Woude FJ Exp Nephrol; 1999; 7(1):1-10. PubMed ID: 9892807 [TBL] [Abstract][Full Text] [Related]
2. Role of endothelin in renal function and dysfunction. Brooks DP Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):345-48. PubMed ID: 8717072 [TBL] [Abstract][Full Text] [Related]
3. The clinical role of endothelin antagonists. Gross P; Kirchengast M Nephrol Dial Transplant; 2001 Apr; 16(4):863-4. PubMed ID: 11274292 [No Abstract] [Full Text] [Related]
10. Endothelin-1-mediated inflammation in acute renal failure. Angerio AD Crit Care Nurs Q; 2006; 29(2):152-6. PubMed ID: 16641652 [TBL] [Abstract][Full Text] [Related]
11. Reversal of proteinuric renal disease and the emerging role of endothelin. Barton M Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of endothelin receptor antagonism in kidney disease. Czopek A; Moorhouse R; Webb DJ; Dhaun N Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(5):R388-97. PubMed ID: 26702154 [TBL] [Abstract][Full Text] [Related]
16. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006 [TBL] [Abstract][Full Text] [Related]
17. Emerging roles for eicosanoids in renal diseases. Câmara NO; Martins JO; Landgraf RG; Jancar S Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):21-7. PubMed ID: 19077685 [TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. Neuhofer W; Pittrow D Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747 [TBL] [Abstract][Full Text] [Related]
19. Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies. Benigni A Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):349-53. PubMed ID: 7552102 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ Hypertension; 2009 Jul; 54(1):113-9. PubMed ID: 19506099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]